Background: Saliva is supersaturated with respect to calcium and phosphate ions. Salivary ions may well play a role in the subsequent adsorption of proteins and consequently in the formation of the acquired enamel pellicle. Among several biological functions, the enamel pellicle forms a selectively permeable barrier that regulates demineralization processes. Aim: The aim of this study was to evaluate the importance of salivary proteins when adsorbed on enamel surface and the resultant protective effect against demineralization without the presence of salivary ions. Methods: Enamel surfaces were coated with whole saliva, parotid saliva, dialyzed whole saliva or dialyzed parotid saliva (molecular weight cutoff 1 kDa). Adsorption was allowed to proceed for a period of 2 h. Enamel specimens were then washed with deionized water and immersed into a demineralization solution of pH 4.5 for 12 days. This solution was used to measure the amount of calcium and phosphate released from enamel specimens after the demineralization period. Results: All coated specimen groups showed a significantly higher protection than those not coated with any type of saliva. In addition, undialyzed saliva (whole saliva and parotid saliva) was more effective in protecting the enamel against demineralization than dialyzed saliva. Conclusion: The present investigation indicates that the ionic composition of saliva can amplify the demineralization protection effect by reducing acid-induced enamel demineralization. Moreover, a protective effect of salivary proteins without presence of ions was demonstrated in this study.

1.
Arends J, Jongebloed WL: The enamel substrate – characteristics of the enamel surface. Swed Dent J 1977;1:215–224.
2.
Bennick A, Cannon M, Madapallimattam G: The nature of the hydroxyapatite-binding site in salivary acidic proline-rich proteins. Biochem J 1979;183:115–126.
3.
Edgar WM: Saliva: its secretion, composition and functions. Br Dent J 1992;172:305–312.
4.
Eggen KH, Rolla G: Further studies on the composition of the acquired enamel pellicle. Scand J Dent Res 1983;91:439–446.
5.
Featherstone JD, Behrman JM, Bell JE: Effect of whole saliva components on enamel demineralization in vitro. Crit Rev Oral Biol Med 1993;4:357–362.
6.
Fujikawa H, Matsuyama K, Uchiyama A, Nakashima S, Ujiie T: Influence of salivary macromolecules and fluoride on enamel lesion remineralization in vitro. Caries Res 2008;42:37–45.
7.
Hannig M, Dobert A, Stigler R, Muller U, Prokhorova SA: Initial salivary pellicle formation on solid substrates studied by AFM. J Nanosci Nanotechnol 2004;4:532–538.
8.
Hannig M, Joiner A: The structure, function and properties of the acquired pellicle. Monogr Oral Sci 2006;19:29–64.
9.
Hay DI: The interaction of human parotid salivary proteins with hydroxyapatite. Arch Oral Biol 1973;18:1517–1529.
10.
Helmerhorst EJ, Alagl AS, Siqueira WL, Oppenheim FG: Oral fluid proteolytic effects on histatin 5 structure and function. Arch Oral Biol 2006;51:1061–1070.
11.
Jensen JL, Lamkin MS, Oppenheim FG: Adsorption of human salivary proteins to hydroxyapatite: a comparison between whole saliva and glandular salivary secretions. J Dent Res 1992;71:1569–1576.
12.
Kautsky MB, Featherstone JD: Effect of salivary components on dissolution rates of carbonated apatites. Caries Res 1993;27:373–377.
13.
Kosoric J, Hector MP, Anderson P: The influence of proteins on demineralization kinetics of hydroxyapatite aggregates. J Biomed Mater Res A 2010;94:972–977.
14.
Margolis HC, Moreno EC: Kinetic and thermodynamic aspects of enamel demineralization. Caries Res 1985;19:22–35.
15.
McDonald EE, Goldberg HA, Tabbara N, Mendes FM, Siqueira WL: Histatin 1 resists proteolytic degradation when adsorbed to hydroxyapatite. J Dent Res 2011;90:268–272.
16.
Oppenheim FG, Salih E, Siqueira WL, Zhang W, Helmerhorst EJ: Salivary proteome and its genetic polymorphisms. Ann NY Acad Sci 2007;1098:22–50.
17.
Siqueira WL, de Oliveira E, Mustacchi Z, Nicolau J: Electrolyte concentrations in saliva of children aged 6–10 years with Down syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:76–79.
18.
Siqueira WL, Helmerhorst EJ, Zhang W, Salih E, Oppenheim FG: Acquired enamel pellicle and its potential role in oral diagnostics. Ann NY Acad Sci 2007a;1098:504–509.
19.
Siqueira WL, Margolis HC, Helmerhorst EJ, Mendes FM, Oppenheim FG: Evidence of intact histatins in the in vivo acquired enamel pellicle. J Dent Res 2010;89:626–630.
20.
Siqueira WL, Custodio W, McDonald EE: New insights into the composition and functions of the acquired enamel pellicle. J Dent Res 2012, Epub ahead of print.
21.
Siqueira WL, Oppenheim FG: Small molecular weight proteins/peptides present in the in vivo formed human acquired enamel pellicle. Arch Oral Biol 2009;54:437–444.
22.
Siqueira WL, Zhang W, Helmerhorst EJ, Gygi SP, Oppenheim FG: Identification of protein components in in vivo human acquired enamel pellicle using LC-ESI-MS/MS. J Proteome Res 2007b;6:2152–2160.
23.
Thomadaki K, Helmerhorst EJ, Tian N, Sun X, Siqueira WL, Walt DR, Oppenheim FG: Whole-saliva proteolysis and its impact on salivary diagnostics. J Dent Res 2011;90:1325–1330.
24.
Zahradnik RT, Propas D, Moreno EC: Effect of salivary pellicle formation time on in vitro attachment and demineralization by Streptococcus mutans. J Dent Res 1978;57:1036–1042.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.